Offer - Urjas Oil for just ₹ 1 X
Velaf 37.5 Mg Tablet ER is a commercial drug that is prescribed in the form of Tablet. Depression are some of its major therapeutic uses. Secondary and off-label uses of Velaf 37.5 Mg Tablet ER have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Velaf 37.5 Mg Tablet ER. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Velaf 37.5 Mg Tablet ER as well, which are listed below. Usually, these side effects of Velaf 37.5 Mg Tablet ER go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Velaf 37.5 Mg Tablet ER's effect during pregnancy is Moderate and Severe while nursing. It is important to know if Velaf 37.5 Mg Tablet ER has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Velaf 37.5 Mg Tablet ER related warnings section.
Velaf 37.5 Mg Tablet ER is contraindicated in people with pre-existing medical conditions like Suicidal Tendency as it can result in adverse effects. The section on Velaf 37.5 Mg Tablet ER contraindications lists all such conditions.
Drug reaction of Velaf 37.5 Mg Tablet ER with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Velaf 37.5 Mg Tablet ER is not safe while driving, and is not addiction.
Velaf 37.5 Mg Tablet ER is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Velaf 37.5 Mg Tablet ER safe for pregnant women?
Velaf can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Velaf right away. Take your doctor's advice before taking it again.
Is the use of Velaf 37.5 Mg Tablet ER safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Velaf. So it is adviced to consult the doctor before using it.
What is the effect of Velaf 37.5 Mg Tablet ER on the Kidneys?
Velaf may have mild side effects on the kidneys.
What is the effect of Velaf 37.5 Mg Tablet ER on the Liver?
Velaf is rarely harmful for the liver.
What is the effect of Velaf 37.5 Mg Tablet ER on the Heart?
Velaf may have mild side effects on the heart. Most people will never see any effect on the heart.
Velaf 37.5 Mg Tablet ER should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Velaf 37.5 Mg Tablet ER unless your doctor advises you to do so -
Is this Velaf 37.5 Mg Tablet ER habit forming or addictive?
No, there is no any evidence that Velaf 37.5 Mg Tablet ER is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Velaf 37.5 Mg Tablet ER as you may feel sleepy.
Is it safe?
Yes, Velaf 37.5 Mg Tablet ER is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, Velaf 37.5 Mg Tablet ER is useful in treating mental disorders.
Interaction between Food and Velaf 37.5 Mg Tablet ER
Taking Velaf 37.5 Mg Tablet ER with food does not cause any problems.
Interaction between Alcohol and Velaf 37.5 Mg Tablet ER
Consumption of alcohol and Velaf 37.5 Mg Tablet ER together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1260-1262
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 462
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Effexor XR® (venlafaxine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Effexor® (venlafaxine hydrochloride)